Access earnings results, analyst expectations, report, slides, earnings call, and transcript.

The earnings call reflects positive financial performance with increased net income, EPS, and deposit growth. The guidance adjustments for da Vinci procedures and gross profit margin are optimistic, and the Q&A indicates rational market competition. Despite some concerns about special mention loans, the overall sentiment is positive, with management providing clear responses. The positive factors outweigh negatives, suggesting a likely stock price increase within 2% to 8% over the next two weeks.
The earnings call summary indicates positive developments: increased guidance for da Vinci procedures and gross profit margins, a strategic focus on expanding minimally invasive cardiac procedures, and leveraging advanced imaging and ASC opportunities. Despite competitive pressures in China, the company is adapting well, with promising SP system growth and new digital offerings. While management avoided specific 2026 projections, the overall sentiment remains optimistic, supported by procedure growth and strategic initiatives. The absence of market cap data limits precise prediction, but the positive guidance and strategic direction suggest a positive stock reaction.
The earnings call highlights strong growth in procedure volumes and successful adoption of the da Vinci 5 system, indicating positive market reception. Despite challenges in the bariatric and China markets, guidance updates reflect strategic adaptability. The Q&A section provides additional insights into growth areas like alternative care sites and new platforms, supporting a positive outlook. However, management's lack of clarity on certain issues tempers the sentiment slightly. Overall, the combination of strong financial performance, strategic initiatives, and positive guidance adjustments suggests a positive stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.